XOMA (XOMAP) Stock Price, News & Analysis

Company Overview

XOMA Royalty Corporation, formerly known as XOMA Corporation, is a biotechnology royalty company. It acquires economic interests in therapeutic products and drug candidates, earning potential income from royalties, milestones and other payments when those products advance through development or reach the market.

The company’s interests span medicines developed by biotechnology and pharmaceutical partners, rather than a portfolio of products it primarily markets itself. Its activities extend XOMA’s history as a biotechnology company involved in discovering and developing antibody-based therapeutics.

XOMA’s royalty interests are tied to products and development programs pursued by partners in multiple markets. XOMAP is the Nasdaq symbol for the company’s Series A preferred stock.

Key Stats

• Today's Range: $24.98 to $24.98
• 50-Day Range: $24.98 to $24.98
• 52-Week Range: $24.93 to $30.00
• Volume: N/A
• Average Volume: 2,224 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 8.65%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:XOMAP
• CIK: 791908
• Web: www.xoma.com
• Phone: 510-204-7200
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $7.65 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A